michael zalutsky
michael zalutsky
professor
Verified email at mc.duke.edu
Title
Cited by
Cited by
Year
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
CJ Wikstrand, LP Hale, SK Batra, ML Hill, PA Humphrey, SN Kurpad, ...
Cancer research 55 (14), 3140-3148, 1995
6101995
Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.
PA Humphrey, AJ Wong, B Vogelstein, MR Zalutsky, GN Fuller, GE Archer, ...
Proceedings of the National Academy of Sciences 87 (11), 4207-4211, 1990
4361990
Pinhole collimation for ultra-high-resolution, small-field-of-view SPECT
RJ Jaszczak, J Li, H Wang, MR Zalutsky, RE Coleman
Physics in Medicine & Biology 39 (3), 425, 1994
3651994
Clinical experience with α-particle–emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6
MR Zalutsky, DA Reardon, G Akabani, RE Coleman, AH Friedman, ...
Journal of Nuclear Medicine 49 (1), 30-38, 2008
3442008
Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia
DE Meyer, GA Kong, MW Dewhirst, MR Zalutsky, A Chilkoti
Cancer research 61 (4), 1548-1554, 2001
3272001
Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly …
DA Reardon, G Akabani, R Edward Coleman, AH Friedman, HS Friedman, ...
Journal of Clinical Oncology 20 (5), 1389-1397, 2002
3002002
Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody
D Colcher, M Zalutsky, W Kaplan, D Kufe, F Austin, J Schlom
Cancer research 43 (2), 736-742, 1983
2821983
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-α and a mutated form of the …
JH Sampson, G Akabani, GE Archer, DD Bigner, MS Berger, AH Friedman, ...
Journal of neuro-oncology 65 (1), 27-35, 2003
2742003
The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target
CJ Wikstrand, CJ Reist, GE Archer, MR Zalutsky, DD Bigner
Journal of neurovirology 4 (2), 148-158, 1998
2421998
Astatine-211-labeled radiotherapeutics an emerging approach to targeted alpha-particle radiotherapy
MR Zalutsky, G Vaidyanathan
Current pharmaceutical design 6 (14), 1433-1455, 2000
2372000
A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine
MR Zalutsky, AS Narula
International Journal of Radiation Applications and Instrumentation. Part A …, 1987
2331987
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.
DD Bigner, MT Brown, AH Friedman, RE Coleman, G Akabani, ...
Journal of clinical oncology 16 (6), 2202-2212, 1998
2251998
A plasmonic gold nanostar theranostic probe for in vivo tumor imaging and photothermal therapy
Y Liu, JR Ashton, EJ Moding, H Yuan, JK Register, AM Fales, J Choi, ...
Theranostics 5 (9), 946, 2015
2182015
A thermally responsive biopolymer for intra-articular drug delivery
H Betre, W Liu, MR Zalutsky, A Chilkoti, VB Kraus, LA Setton
Journal of controlled release 115 (2), 175-182, 2006
1992006
Salvage radioimmunotherapy with murine iodine-131–labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: Phase …
DA Reardon, G Akabani, RE Coleman, AH Friedman, HS Friedman, ...
Journal of clinical oncology 24 (1), 115-122, 2006
1972006
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
JH Sampson, G Akabani, GE Archer, MS Berger, RE Coleman, ...
Neuro-oncology 10 (3), 320-329, 2008
1952008
In situ growth of a stoichiometric PEG-like conjugate at a protein's N-terminus with significantly improved pharmacokinetics
W Gao, W Liu, JA Mackay, MR Zalutsky, EJ Toone, A Chilkoti
Proceedings of the National Academy of Sciences 106 (36), 15231-15236, 2009
1882009
Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with α-, β-, and Auger electron–emitting radionuclides
M Boyd, SC Ross, J Dorrens, NE Fullerton, KW Tan, MR Zalutsky, ...
Journal of nuclear medicine 47 (6), 1007-1015, 2006
1762006
Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies
MR Zalutsky, RP Moseley, HB Coakham, RE Coleman, DD Bigner
Cancer research 49 (10), 2807-2813, 1989
1761989
Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F] fluorobenzoate
G Vaidyanathan, MR Zalutsky
International journal of radiation applications and instrumentation. Part B …, 1992
1741992
The system can't perform the operation now. Try again later.
Articles 1–20